Episode 7 of Mount Sinai Future You highlights innovation in science and features one artist’s battle with late stage, drug resistant, multiple myeloma. With the research of Samir Parekh, MD, Director of Multiple Myeloma Translational Research at the Icahn School of Medicine at Mount Sinai, the patient participated in a clinical trial that helped him achieve his dream of finishing a painting that had been in the works for 40 years.
Mount Sinai Future You, Episode 7, also features:
- Clinicians from the Tisch Cancer Institute at Mount Sinai discussing advances in cancer treatments
- William Oh, MD, Chief of the Division of Hematology and Medical Oncology and Deputy Director of the Tisch Cancer Institute at Mount Sinai, shows how rapidly cycling prostate cancer medications may prevent drug resistance
- Ash Tewari, MD, System Chair of the Department of Urology at the Icahn School of Medicine at Mount Sinai, and Dennis Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, raise awareness for prostate health with a push-up challenge
- Barry A. Salky, MD, Chief Emeritus of the Division of Laparoscopic Surgery at Mount Sinai, and an alumni of the Icahn School of Medicine at Mount Sinai, discusses minimally invasive surgical techniques
- Alfred Iloreta, MD, Assistant Professor of Otolaryngology and member of the Division of Endoscopic Skull Base Surgery at the Icahn School of Medicine at Mount Sinai, performs minimally invasive surgery on a patient who had been misdiagnosed for years
- Nina Bhardwaj, MD, PhD, Director of Immunotherapy at the Icahn School of Medicine at Mount Sinai, uses precision medicine to develop a personalized vaccine to attack cancer mutations
- James Ferrara, MD, Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai, leads a study that uses the lining of the gastrointestinal tract to create a new class of drugs
- Edward Wolin, MD, Director of Carcinoid and Neuroendocrine Tumor Center at the Tisch Cancer Institute at Mount Sinai and William Oh, MD, Chief of the Division of Hematology and Medical Oncology and Deputy Director of the Tisch Cancer Institute at Mount Sinai, discuss the development of advanced imaging procedures for treating tumors in the gastrointestinal system